Pharmacotherapy for obesity: are we ready to select, tailor and combine pharmacotherapy to achieve more ambitious goals?

Recent advancements in obesity pharmacotherapy have seen the approval of novel agents, like glucagon-like peptide-1 receptor agonist and dual agonists, offering unprecedented efficacy for obesity management. However, treatment outcomes remain highly variable, necessitating a more personalized approa...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Nele Steenackers, Julia Toumassian, Ellen Deleus, Ann Mertens, Matthias Lannoo, Sofia Pazmino, Amar Daniël Emanuel van Laar, Bart Van der Schueren, Roman Vangoitsenhoven
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-06-01
Serija:	Frontiers in Endocrinology
Teme:	obesity obesity pharmacotherapy precision medicine personalized treatment combination therapy weight management
Online dostop:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1569468/full
Oznake:	Označite Brez oznak, prvi označite!